A Randomized, Double-Blinded, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-903452 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 14 Mar 2012
At a glance
- Drugs BMS 903452 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 14 Mar 2012 Actual patient number 104 added as reported by ClinicalTrials.gov.
- 14 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2012 Planned end date changed from 1 Nov 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.